Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 263
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
MYND Life Sciences announces Depression Biomarker Diagnostic Program
Horizons ETFs Announces Methodology Update for the North American Psychedelics Index
Filament Health Partners with TrPR Psychedelic Research Program at UCSF to...
Can Psychedelics Help Heal Moral Injury?
Psychedelic Bulletin: COMPASS Pathways’ 4th Patent; MagicMed to Be Acquired; MindMed...
MindMed announces shareholder Meeting Results
PTSF61 – Archetypal Astrology and the Inner Healer, with Renn Butler
MYND Life Sciences Inc. Establishes Scientific Advisory Board
The Psilocybin vs. Escitalopram Trial – Part 1
Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory...
Load more